Summary of first quarter 2015

Peter Rothschild, President of BioGaia, summarises the first quarter of 2015 and answers questions regarding;

• main reasons to strong results in first quarter,
• the Brasilian market and its future,
• agreement with Nestlé regarding development of new products,
• the BioGaia subsidary IBT (Infant Bacterial Therapeutics) and its NEC-project,
• and the new agreement in Mexico regarding sales of Oral Health tablets